Please login to the form below
Takeda highlights 12 NMEs with $10bn-plus sales potential at R&D day
First wave of new molecular entities has potential to generate 14 approvals
BeiGene bags FDA approval for first product Brukinsa in lymphoma
Also the first approval for a Chinese-developed cancer drug in US
Amarin wins FDA advisory nod for Vascepa cardiovascular expansion
Approval likely for fish-oil derived drug following speedy review
Shionogi scores FDA approval for new cUTI antibiotic
Pivotal new treatment for adults with complicated urinary tract infection
Merck acquires pre-clinical biotech Calporta for up to $576m
Expands into early-stage neurodegeneration research field
FDA advisors say no to empagliflozin in type 1 diabetes
Approval of Boehringer, Lilly-partnered drug expansion looks unlikely
MSD hangs ‘for sale’ sign on French facility, shedding 207 staff
Job losses will be across manufacturing and R&D divisions
World Diabetes Day 2019
Many lack knowledge around type 2 diabetes risk factors, says new survey
AbbVie sells $30bn of bonds ahead of Allergan merger
Will use net proceeds to fund cash consideration due to shareholders
Q&A: Steve Clark
PME interviews the director of Redwood Brand Curators
-
Q&A: Chris McPhersonPME interviews ENGINE | MHP's account director, health
-
Q&A: Jessica PaceyPME interviews the founder and chief executive of newly launched health comms agency, 67health
-
Syneos Health announces partnership with AiCureWill leverage proprietary intelligent software and AI-driven insights
-
Election 2019: Labour tops Tory pledge on NHS spendingPledge comes as campaigning for upcoming election gathers steam
-
Nucala works in rare inflammatory disease, says GSKCompany is planning to file for approval in indication next year
-
Solid Bio falls as FDA halts DMD trial over safety concerns Shares in the biotech dropped dramatically following the announcement
-
ZPB Associates acquires PR specialist Journalista Agencies have previously worked together on a number of campaigns
-
BMS scores FDA priority review for Opdivo/Yervoy combo in liver cancerPossible new treatment for difficult to treat cancer type
-
Merck claims first-ever okay for Ebola vaccine, in EuropeComes shortly after J&J filed its Ebola candidate with EMA
Latest appointments
-
New faces at creative digital agency earthwareEmma Green and Melanie Charles join the team
-
New faces at Healthware Group and HRWThe latest movers in healthcare comms
-
New faces at Prime Global, Swordfish Advertising and Wilmington HealthcareThe latest movers in healthcare comms
-
New hires at Amgen, Eli Lilly and Zosano The latest movers in pharma
-
Red Consultancy appoints MD in its health divisionAvril Lee brings over 20 years' experience to company
Featured jobs
-
Account Director
-
Salary TBC
-
Account Supervisor
-
Salary TBC
- Senior Editor - Medical Communications - South East - Buckingham...
-
Highly competitive salary &package
- Scientific Director - Medical Communications - Berkshire
-
Excellent package on offer
-
Senior Medical Writer
-
Salary TBC
-
Account Director, Medical Education
-
Salary TBC
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Account Executive
-
Salary TBC
- Entry Level Editorial Assistant – Medical Education –Buckinghams...
-
Highly Competitive
Subscribe to our email news alerts
- The first of many celebrations for Lucid Group at Middlesex House
- FDA advisors say no to empagliflozin in type 1 diabetes
- Roche’s Spinraza, Zolgensma rival risdiplam hits the mark in SMA
- MSD hangs ‘for sale’ sign on French facility, shedding 207 staff
- Novartis makes case for NASH candidate tropifexor
- Takeda highlights 12 NMEs with $10bn-plus sales potential at R&D day
- RWE Blog 3: Is real-world evidence the holy grail
- What do Healthcare Professionals think about the inclusion of remote selling techniques?
- Takeda highlights 12 NMEs with $10bn-plus sales potential at R&D day
- BeiGene bags FDA approval for first product Brukinsa in lymphoma
- Amarin wins FDA advisory nod for Vascepa cardiovascular expansion
- Shionogi scores FDA approval for new cUTI antibiotic
PMHub
CSafe Global
CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...
Latest intelligence
- RWE Blog 3: Is real-world evidence the holy grail
- We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use...
- What do Healthcare Professionals think about the inclusion of remote selling techniques?
- Evolving to a digitally focused pharma / healthcare company - an organisational roadmap...
- Strengthening business competition and reducing anti-competitive practices
- How the CMA is tackling high prices for essential drugs...
Quick links
Infographics
